Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
Novel human IgG1 and IgG4 Fc-engineered antibodies with completely abolished immune effector functions. [electronic resource] by
- Schlothauer, Tilman
- Herter, Sylvia
- Koller, Claudia Ferrara
- Grau-Richards, Sandra
- Steinhart, Virginie
- Spick, Christian
- Kubbies, Manfred
- Klein, Christian
- Umaña, Pablo
- Mössner, Ekkehard
Producer: 20170503
In:
Protein engineering, design & selection : PEDS vol. 29
Availability: No items available.
|
|
5.
|
P329G-CAR-J: a novel Jurkat-NFAT-based CAR-T reporter system recognizing the P329G Fc mutation. [electronic resource] by
- Darowski, Diana
- Jost, Christian
- Stubenrauch, Kay
- Wessels, Uwe
- Benz, Jörg
- Ehler, Andreas
- Freimoser-Grundschober, Anne
- Brünker, Peter
- Mössner, Ekkehard
- Umaña, Pablo
- Kobold, Sebastian
- Klein, Christian
Producer: 20200625
In:
Protein engineering, design & selection : PEDS vol. 32
Availability: No items available.
|
|
6.
|
GA101 P329GLALA, a variant of obinutuzumab with abolished ADCC, ADCP and CDC function but retained cell death induction, is as efficient as rituximab in B-cell depletion and antitumor activity. [electronic resource] by
- Herter, Sylvia
- Herting, Frank
- Muth, Gunter
- van Puijenbroek, Erwin
- Schlothauer, Tilman
- Ferrara, Claudia
- Brady, Kevin
- Lang, Sabine
- Bacac, Marina
- Mössner, Ekkehard
- Umana, Pablo
- Klein, Christian
Producer: 20190219
In:
Haematologica vol. 103
Availability: No items available.
|
|
7.
|
Biochemical and biophysical characterization of purified native CD20 alone and in complex with rituximab and obinutuzumab. [electronic resource] by
- Agez, Morgane
- Mandon, Elodie Desuzinges
- Iwema, Thomas
- Gianotti, Reto
- Limani, Florian
- Herter, Sylvia
- Mössner, Ekkehard
- Kusznir, Eric A
- Huber, Sylwia
- Lauer, Matthias
- Ringler, Philippe
- Ferrara, Claudia
- Klein, Christian
- Jawhari, Anass
Producer: 20201030
In:
Scientific reports vol. 9
Availability: No items available.
|
|
8.
|
Epitope characterization and crystal structure of GA101 provide insights into the molecular basis for type I/II distinction of CD20 antibodies. [electronic resource] by
- Niederfellner, Gerhard
- Lammens, Alfred
- Mundigl, Olaf
- Georges, Guy J
- Schaefer, Wolfgang
- Schwaiger, Manfred
- Franke, Andreas
- Wiechmann, Kornelius
- Jenewein, Stefan
- Slootstra, Jerry W
- Timmerman, Peter
- Brännström, Annika
- Lindstrom, Frida
- Mössner, Ekkehard
- Umana, Pablo
- Hopfner, Karl-Peter
- Klein, Christian
Producer: 20110927
In:
Blood vol. 118
Availability: No items available.
|
|
9.
|
Increasing the efficacy of CD20 antibody therapy through the engineering of a new type II anti-CD20 antibody with enhanced direct and immune effector cell-mediated B-cell cytotoxicity. [electronic resource] by
- Mössner, Ekkehard
- Brünker, Peter
- Moser, Samuel
- Püntener, Ursula
- Schmidt, Carla
- Herter, Sylvia
- Grau, Roger
- Gerdes, Christian
- Nopora, Adam
- van Puijenbroek, Erwin
- Ferrara, Claudia
- Sondermann, Peter
- Jäger, Christiane
- Strein, Pamela
- Fertig, Georg
- Friess, Thomas
- Schüll, Christine
- Bauer, Sabine
- Dal Porto, Joseph
- Del Nagro, Christopher
- Dabbagh, Karim
- Dyer, Martin J S
- Poppema, Sibrand
- Klein, Christian
- Umaña, Pablo
Producer: 20100623
In:
Blood vol. 115
Availability: No items available.
|
|
10.
|
RG7386, a Novel Tetravalent FAP-DR5 Antibody, Effectively Triggers FAP-Dependent, Avidity-Driven DR5 Hyperclustering and Tumor Cell Apoptosis. [electronic resource] by
- Brünker, Peter
- Wartha, Katharina
- Friess, Thomas
- Grau-Richards, Sandra
- Waldhauer, Inja
- Koller, Claudia Ferrara
- Weiser, Barbara
- Majety, Meher
- Runza, Valeria
- Niu, Huifeng
- Packman, Kathryn
- Feng, Ningping
- Daouti, Sherif
- Hosse, Ralf J
- Mössner, Ekkehard
- Weber, Thomas G
- Herting, Frank
- Scheuer, Werner
- Sade, Hadassah
- Shao, Cuiying
- Liu, Bin
- Wang, Peng
- Xu, Gary
- Vega-Harring, Suzana
- Klein, Christian
- Bosslet, Klaus
- Umaña, Pablo
Producer: 20170629
In:
Molecular cancer therapeutics vol. 15
Availability: No items available.
|
|
11.
|
Tumor-targeted 4-1BB agonists for combination with T cell bispecific antibodies as off-the-shelf therapy. [electronic resource] by
- Claus, Christina
- Ferrara, Claudia
- Xu, Wei
- Sam, Johannes
- Lang, Sabine
- Uhlenbrock, Franziska
- Albrecht, Rosmarie
- Herter, Sylvia
- Schlenker, Ramona
- Hüsser, Tamara
- Diggelmann, Sarah
- Challier, John
- Mössner, Ekkehard
- Hosse, Ralf J
- Hofer, Thomas
- Brünker, Peter
- Joseph, Catherine
- Benz, Jörg
- Ringler, Philippe
- Stahlberg, Henning
- Lauer, Matthias
- Perro, Mario
- Chen, Stanford
- Küttel, Christine
- Bhavani Mohan, Preethi L
- Nicolini, Valeria
- Birk, Martina Carola
- Ongaro, Amandine
- Prince, Christophe
- Gianotti, Reto
- Dugan, Gregory
- Whitlow, Christopher T
- Solingapuram Sai, Kiran Kumar
- Caudell, David L
- Burgos-Rodriguez, Armando G
- Cline, J Mark
- Hettich, Michael
- Ceppi, Maurizio
- Giusti, Anna Maria
- Crameri, Flavio
- Driessen, Wouter
- Morcos, Peter N
- Freimoser-Grundschober, Anne
- Levitsky, Victor
- Amann, Maria
- Grau-Richards, Sandra
- von Hirschheydt, Thomas
- Tournaviti, Stella
- Mølhøj, Michael
- Fauti, Tanja
- Heinzelmann-Schwarz, Viola
- Teichgräber, Volker
- Colombetti, Sara
- Bacac, Marina
- Zippelius, Alfred
- Klein, Christian
- Umaña, Pablo
Producer: 20200629
In:
Science translational medicine vol. 11
Availability: No items available.
|